Tobacco use, insulin resistance, and risk of type 2 diabetes: Results from the multi-ethnic study of atherosclerosis

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Keith, Rachel J ^a,b   Al Rifai, Mahmoud ^b,c   Carruba, Christopher ^d   De Jarnett, Natasha ^a,b   McEvoy, John W ^c   Bhatnagar, Aruni ^a,b   Blaha, Michael J ^b,c   Defilippis, Andrew P ^a,b,c  

^a University of Louisville School of Medicine   (United States)

^b AMERICAN HEART ASSOCIATION   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; SEX DIFFERENCE; SMOKELESS TOBACCO; SMOKING HABIT; TOBACCO USE; ADVERSE EFFECTS; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; ETHNIC GROUP; ETHNOLOGY; INCIDENCE; METABOLISM; ODDS RATIO; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEXUAL DEVELOPMENT; SMOKING; STATISTICS AND NUMERICAL DATA;

ATHEROSCLEROSIS; BIOMARKERS; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; SMOKING; TOBACCO USE;

EID: 84976891162     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157592     Document Type: Article

References (53)

1. Haussmann HJ. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chemical research in toxicology. 2012; 25(4):794-810. Epub 2012/02/23. doi: 10.1021/tx200536w PMID: 22352345.
2. Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2008; 10(12):1773-82. doi: 10.1080/14622200802443544 PMID: 19023828; PubMed Central PMCID: PMC2892835.
3. Eliasson B. Cigarette smoking and diabetes. Progress in cardiovascular diseases. 2003; 45(5):405-13. Epub 2003/04/22. doi: 10.1053/pcad.2003.00103 PMID: 12704597.
4. Seet RC, Loke WM, Khoo CM, Chew SE, Chong WL, Quek AM, et al. Acute effects of cigarette smoking on insulin resistance and arterial stiffness in young adults. Atherosclerosis. 2012; 224(1):195-200. Epub 2012/07/31. doi: 10.1016/j.atherosclerosis.2012.06.060 PMID: 22840427.
5. Services USDoHaH. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health., 2014.
6. Pan A, Wang Y, Talaei M, Hu FB, Wu T. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. The lancet Diabetes & endocrinology. 2015. Epub 2015/09/22. doi: 10.1016/s2213-8587(15)00316-2 PMID: 26388413.
7. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. Jama. 2007; 298(22):2654-64. Epub 2007/12/13. doi: 10.1001/jama.298.22.2654 PMID: 18073361.
8. Ostenson CG, Hilding A, Grill V, Efendic S. High consumption of smokeless tobacco ("snus") predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men. Scandinavian journal of public health. 2012; 40(8):730-7. Epub 2012/11/03. doi: 10.1177/1403494812459814 PMID: 23117209.
9. Persson PG, Carlsson S, Svanstrom L, Ostenson CG, Efendic S, Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. Journal of internal medicine. 2000; 248(2):103-10. Epub 2000/08/18. PMID: 10947888.
10. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992; 339(8802):1128-30. PMID: 1349365.
11. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. The American journal of clinical nutrition. 2008; 87(4):801-9. Epub 2008/04/11. PMID: 18400700.
12. Twig G, Afek A, Derazne E, Tzur D, Cukierman-Yaffe T, Gerstein HC, et al. Diabetes Risk Among Overweight and Obese Metabolically Healthy Young Adults. Diabetes care. 2014. Epub 2014/08/21. doi: 10.2337/dc14-0869 PMID: 25139886.
13. Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N, et al. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obesity research. 2005; 13(8):1466-75. Epub 2005/09/01. doi: 10.1038/oby.2005.177 PMID: 16129730.
14. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkanen L, Selby J, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996; 45(6):742-8. Epub 1996/06/01. PMID: 8635647.
15. Henninger J, Hammarstedt A, Rawshani A, Eliasson B. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population - A prospective cohort study. BMC endocrine disorders. 2015; 15(1):51. Epub 2015/09/27. doi: 10.1186/s12902-015-0048-8 PMID: 26407933; PubMed Central PMCID: PMCPmc4583989.
16. Zinser MC, Pampel FC, Flores E. Distinct Beliefs, Attitudes, and Experiences of Latino Smokers: Relevance for Cessation Interventions. American Journal of Health Promotion. 2011; 25(sp5):eS1-eS15. doi: 10.4278/ajhp.100616-QUAN-200
17. Mustonen TK, Spencer SM, Hoskinson RA, Sachs DP, Garvey AJ. The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2005; 7(4):581-90. doi: 10.1080/14622200500185199 PMID: 16085529.
18. Prevention CfDCaPNCfCDPaHPOoSaHCfDCa. The Changing Cigarette. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General2010.
19. Hoffmann D, Hoffmann I, El-Bayoumy K. The Less Harmful Cigarette: A Controversial Issue. A Tribute to Ernst L. Wynder. Chemical research in toxicology. 2001; 14(7):767-90. doi: 10.1021/tx000260u PMID: 11453723
20. Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health. 1994; 41(1):1-52. Epub 1994/01/01. doi: 10.1080/15287399409531825 PMID: 8277523.
21. Sarkar M, Wang J, Liang Q. Metabolism of nicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone (NNK) in menthol and non-menthol cigarette smokers. Drug Metab Lett. 2012; 6(3):198-206. Epub 2012/11/13. PMID: 23140558.
22. Axelsson T, Jansson PA, Smith U, Eliasson B. Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects. J Intern Med. 2001; 249(6):539-44. Epub 2001/06/26. PMID: 11422660.
23. Beziaud F, Halimi JM, Lecomte P, Vol S, Tichet J. Cigarette smoking and diabetes mellitus. Diabetes & metabolism. 2004; 30(2):161-6. Epub 2004/06/30. PMID: 15223988.
24. Madsbad S, McNair P, Christensen MS, Christiansen C, Faber OK, Binder C, et al. Influence of smoking on insulin requirement and metbolic status in diabetes mellitus. Diabetes care. 1980; 3(1):41-3. Epub 1980/01/01. PMID: 6996967.
25. Soulimane S, Simon D, Herman WH, Lange C, Lee CM, Colagiuri S, et al. HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia. 2014; 57(1):30-9. Epub 2013/09/26. doi: 10.1007/s00125-013-3058-y PMID: 24065153.
26. Nagaya T, Yoshida H, Takahashi H, Kawai M. Heavy smoking raises risk for type 2 diabetes mellitus in obese men; but, light smoking reduces the risk in lean men: a follow-up study in Japan. Annals of epidemiology. 2008; 18(2):113-8. Epub 2007/12/18. doi: 10.1016/j.annepidem.2007.07.107 PMID: 18083537.
27. Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, et al. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clinical pharmacology and therapeutics. 2006; 80(3):282-97. doi: 10.1016/j.clpt.2006.05.012 PMID: 16952495.
28. Fukami T, Nakajima M, Yamanaka H, Fukushima Y, McLeod HL, Yokoi T. A novel duplication type of CYP2A6 gene in African-American population. Drug metabolism and disposition: the biological fate of chemicals. 2007; 35(4):515-20. doi: 10.1124/dmd.106.013557 PMID: 17267622.
29. Xia Y, Bernert JT, Jain RB, Ashley DL, Pirkle JL. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals. 2011; 16(2):112-9. Epub 2010/12/01. doi: 10.3109/1354750x.2010.533288 PMID: 21114376.
30. Wang L, Rundek T, Beecham A, Hudson B, Blanton SH, Zhao H, et al. Genome-wide interaction study identifies RCBTB1 as a modifier for smoking effect on carotid intima-media thickness. Arteriosclerosis, thrombosis, and vascular biology. 2014; 34(1):219-25. doi: 10.1161/ATVBAHA.113.302706 PMID: 24202307.
31. Henley SJ, Thun M, Connell C, Calle E. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control. 2005; 16(4):347-58. doi: 10.1007/s10552-004-5519-6 PMID: 15953977
32. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multi-ethnic study of atherosclerosis: objectives and design. American journal of epidemiology. 2002; 156(9):871-81. Epub 2002/10/25. PMID: 12397006.
33. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environmental health perspectives. 1999; 107 Suppl 2:349-55. Epub 1999/06/03. PMID: 10350520; PubMed Central PMCID: PMCPmc1566286.
34. Levin G, Kestenbaum B, Ida Chen YD, Jacobs DR Jr., Psaty BM, Rotter JI, et al. Glucose, insulin, and incident hypertension in the multi-ethnic study of atherosclerosis. American journal of epidemiology. 2010; 172(10):1144-54. Epub 2010/10/22. doi: 10.1093/aje/kwq266 PMID: 20961972; PubMed Central PMCID: PMCPmc3004765.
35. McEvoy JW, Nasir K, DeFilippis AP, Lima JA, Bluemke DA, Hundley WG, et al. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2015; 35(4):1002-10. Epub 2015/03/07. doi: 10.1161/atvbaha.114.304960 PMID: 25745060.
36. McEvoy JW, Blaha MJ, DeFilippis AP, Lima JA, Bluemke DA, Hundley WG, et al. Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis from the MultiEthnic Study of Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2015; 35(3):700-9. Epub 2015/01/13. doi: 10.1161/atvbaha.114.304562 PMID: 25573855; PubMed Central PMCID: PMCPmc4404404.
37. Onat A, Ozhan H, Esen AM, Albayrak S, Karabulut A, Can G, et al. Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women - without associated overall health benefit. Atherosclerosis. 2007; 193(2):380-8. Epub 2006/08/24. doi: 10.1016/j.atherosclerosis.2006.07.002 PMID: 16926017.
38. McCulloch P, Lee S, Higgins R, McCall K, Schade DS. Effect of smoking on hemoglobin A1c and body mass index in patients with type 2 diabetes mellitus. Journal of investigative medicine: the official publication of the American Federation for Clinical Research. 2002; 50(4):284-7. Epub 2002/07/12. PMID: 12109592.
39. Berlin I. Smoking-induced metabolic disorders: a review. Diabetes & metabolism. 2008; 34(4 Pt 1):307-14. Epub 2008/05/13. doi: 10.1016/j.diabet.2008.01.008 PMID: 18468932.
40. Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethnicity & disease. 2007; 17(1):143-52. Epub 2007/02/06. PMID: 17274224.
41. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ (Clinical research ed). 2009; 338:b880. Epub 2009/03/20. doi: 10.1136/bmj.b880 PMID: 19297312; PubMed Central PMCID: PMCPmc2659857.
42. Mickens L, Ameringer K, Brightman M, Leventhal AM. Epidemiology, determinants, and consequences of cigarette smoking in African American women: An integrative review. Addictive Behaviors. 2010; 35(5):383-91. doi: 10.1016/j.addbeh.2009.12.014 PMID: 20061090
43. Hu H, Huff CD, Yamamura Y, Wu X, Strom SS. The Relationship between Native American Ancestry, Body Mass Index and Diabetes Risk among Mexican-Americans. PloS one. 2015; 10(10):e0141260. Epub 2015/10/27. doi: 10.1371/journal.pone.0141260 PMID: 26501420; PubMed Central PMCID: PMCPmc4621045.
44. Palaniappan LP, Carnethon MR, Fortmann SP. Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin. Diabetes care. 2002; 25(8):1351-7. Epub 2002/07/30. PMID: 12145234; PubMed Central PMCID: PMCPmc3121929.
45. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997; 315(7109):629-34. Epub 1997/10/06. PMID: 9310563; PubMed Central PMCID: PMCPmc2127453.
46. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991; 337(8746):867-72. Epub 1991/04/13. PMID: 1672966.
47. Misakian AL, Bero LA. Publication bias and research on passive smoking: comparison of published and unpublished studies. JAMA: the journal of the American Medical Association. 1998; 280(3):250-3. Epub 1998/07/24. PMID: 9676672.
48. Montori VM, Smieja M, Guyatt GH. Publication bias: a brief review for clinicians. Mayo Clinic proceedings. 2000; 75(12):1284-8. Epub 2000/12/29. doi: 10.4065/75.12.1284 PMID: 11126838.
49. Foy CG, Bell RA, Farmer DF, Goff DC, Wagenknecht LE. Smoking and Incidence of Diabetes Among U.S. Adults: Findings from the Insulin Resistance Atherosclerosis Study. Diabetes care. 2005; 28(10):2501-7. PMID: 16186287
50. Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of diabetes in older Australians: the Blue Mountains Eye Study. The Medical journal of Australia. 2007; 186(3):131-5. Epub 2007/02/21. PMID: 17309402.
51. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. European heart journal. 2005; 26(17):1765-73. Epub 2005/04/09. doi: 10.1093/eurheartj/ehi183 PMID: 15817606.
52. Barrett-Connor E, Khaw KT. Cigarette smoking and increased central adiposity. Annals of internal medicine. 1989; 111(10):783-7. Epub 1989/11/15. PMID: 2817625.
53. Dhar P. Measuring tobacco smoke exposure: quantifying nicotine/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methods. Journal of pharmaceutical and biomedical analysis. 2004; 35(1):155-68. Epub 2004/03/20. doi: 10.1016/j.jpba.2004.01.009 PMID: 15030890.